MoneyWorks4Me

Lupin informs about press release

14 Nov 2025 Evaluate
Lupin has informed that it enclosed a Press Release titled ‘Lupin Launches Risperidone Long-Acting Injectable with 180- day CGT exclusivity in the U.S., the First Product from its Proprietary Long-Acting Injectable Platform PrecisionSphere’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..